Serial Number
76296801
Owner
Hydra Biosciences, Inc.Attorney
Michael J. Bevilacqua, EsquireFiling Date
Aug 8, 2001
HYDRA Trademark
Serial Number: 76296801
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
August 8, 2001
Registration Date
Not Registered
Published for Opposition
December 27, 2005
Goods & Services
Pharmaceuticals preparations for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules, excluding pharmaceutical preparations for the treatment of skin conditions, namely dry skin and eczema; pharmaceutical preparations in the nature of biologicals for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules, excluding pharmaceutical preparations for the treatment of skin conditions, namely dry skin and eczema; and pharmaceutical preparations in the nature of genetic therapies for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules, excluding pharmaceutical preparations for the treatment of skin conditions, namely dry skin and eczema; oral contraceptives; spermicides; tests and assays composed primarily of mammalian cells, ion channels, signaling molecules, dedifferentiated or dedifferentiating cells, and cellular contractile organizational structures for identifying molecules that can induce desirable cardiovascular, reproductive, genitourinary, gastrointestinal, infectious, hematologic, oncologic, metabolic, neurologic, pulmonary, immunologic, renal, rheumatologic, dermatologic or vision results; and tests and assays composed primarily of mammalian cells, ion channels, signaling molecules, dedifferentiated or dedifferentiating cells, and cellular contractile organizational structures for identifying a risk of cardiovascular, reproductive, genitourinary, gastrointestinal, infectious, hematologic, oncologic, metabolic, neurologic, pulmonary, immunologic, renal, rheumatologic, dermatologic and vision diseases
